ECOG performance status was found to capture only part of the patient experience in gastric/GEJ adenocarcinoma. Among patients with gastric or gastroesophageal junction (GEJ) adenocarcinoma, those ...

Analysis of the phase 3 explorer7 (NCT04083781) study indicates a preference for concizumab prophylaxis over no prophylaxis in patients with hemophilia A or B with inhibitors. Among individuals with ...

Improved QOL is observed in patients over two years post-infusion and those without disease progression, highlighting the ...

Measuring treatment success in Sjögren's disease requires more than tracking systemic disease activity alone. Fatigue, pain, ...

The number and frequency of intravesical instillations for non-muscle-invasive bladder cancer (NMIBC) impairs quality of life and needs to be reported in clinical trials.

A recent study reveals comparable outcomes for radical cystectomy and bladder-sparing therapy in treating recurrent ...

Only a minority of the instruments used in clinical and research settings to evaluate patient-reported outcome measures (PROMs) in CVD care adhere to quality standards set by the US Food and Drug ...

When doctors and insurers want to evaluate a patient’s health status, they typically use objective and broad measures, such as laboratory and vital sign measures like blood pressure or hemoglobin A1c, ...

Just as clinical trial design and rigor have evolved with improvements in methods and processes, so too have methods for capturing patient data in clinical trials. Substantial evidence suggests that ...